Cardiology

Top Story

Trial assessing drug-coated balloon for PAD underway

August 1, 2015

The Spectranetics Corporation announced that enrollment is completed for the ILLUMNENATE Pivotal trial, which is evaluating the use of a drug-coated angioplasty balloon to treat patients with peripheral artery disease.

The Stellarex drug-coated balloon platform (Spectranetics) is intended to restore and maintain blood flow in leg arteries above the knee in this patient population, according to a company press release. The prospective, randomized ILLUMENATE Pivotal will include 300 patients with superficial femoral or popliteal artery lesions of 3 to 14 cm. Patients were enrolled at 42 U.S. sites.

In the Journals

ADVICE: Adenosine-guided pulmonary vein isolation during AF ablation safe, effective

July 31, 2015
When adenosine testing was used to identify dormant pulmonary vein conduction in patients with atrial fibrillation undergoing catheter ablation, the rate of…
In the Journals

Self-expandable TAVR system yields low stroke rates

July 31, 2015
A self-expandable transcatheter aortic valve replacement system was associated with low early and late stroke rates in high-risk patients with aortic stenosis, according…

AAFP, ACP join nearly 600 other organizations in support of clinical data transparency

July 31, 2015
The American Academy of Family Physicians and the American College of Physicians has announced their support of the AllTrials campaign, joining 595 other organizations…

Uptake of secondary CVD prevention measures low worldwide, strategies to reduce mortality outlined

July 31, 2015
It is estimated that one-quarter of the 35 million acute coronary or cerebrovascular events that occur worldwide each year are in individuals with previous heart disease…
More News Headlines »
CME
PCI in ACS: Deciding Among Clopidogrel, Prasugrel, or Ticagrelor

PCI in ACS: Deciding Among Clopidogrel, Prasugrel, or Ticagrelor

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

It is estimated that in the United States, each year, over 780,000 persons will experience an acute coronary syndrome…
More »
Video
VIDEO: Joseph Rossano, MD, MS, discusses benefits of VADs for children with advanced HF

VIDEO: Joseph Rossano, MD, MS, discusses benefits of VADs for children with advanced HF

July 17, 2015
PHILADELPHIA — In this video, Joseph Rossano, MD, MS, FAAP, FAAC, medical director of HF/transplantation at…
More »
CME
Highlights from Lipid Forum 2015™: Focus on Hypertriglyceridemia

Highlights from Lipid Forum 2015®: Focus on Hypertriglyceridemia

This activity is supported by an educational grant from AstraZeneca.

Hypertriglyceridemia is a highly prevalent yet modifiable risk factor for atherosclerotic disease, pancreatitis, and…
More »
morganatic-roan
morganatic-roan